Correlation Between Enzo Biochem and Neuronetics
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and Neuronetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and Neuronetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and Neuronetics, you can compare the effects of market volatilities on Enzo Biochem and Neuronetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of Neuronetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and Neuronetics.
Diversification Opportunities for Enzo Biochem and Neuronetics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Enzo and Neuronetics is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and Neuronetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuronetics and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with Neuronetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuronetics has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and Neuronetics go up and down completely randomly.
Pair Corralation between Enzo Biochem and Neuronetics
Considering the 90-day investment horizon Enzo Biochem is expected to under-perform the Neuronetics. But the stock apears to be less risky and, when comparing its historical volatility, Enzo Biochem is 1.79 times less risky than Neuronetics. The stock trades about -0.22 of its potential returns per unit of risk. The Neuronetics is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 100.00 in Neuronetics on November 28, 2024 and sell it today you would earn a total of 357.00 from holding Neuronetics or generate 357.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Enzo Biochem vs. Neuronetics
Performance |
Timeline |
Enzo Biochem |
Neuronetics |
Enzo Biochem and Neuronetics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enzo Biochem and Neuronetics
The main advantage of trading using opposite Enzo Biochem and Neuronetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, Neuronetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuronetics will offset losses from the drop in Neuronetics' long position.Enzo Biochem vs. Fonar | Enzo Biochem vs. Burning Rock Biotech | Enzo Biochem vs. Sera Prognostics | Enzo Biochem vs. DarioHealth Corp |
Neuronetics vs. Burning Rock Biotech | Neuronetics vs. DarioHealth Corp | Neuronetics vs. Sera Prognostics | Neuronetics vs. Biodesix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Valuation Check real value of public entities based on technical and fundamental data |